Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Drugs in tuberculosis and leprosy
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drugs in tuberculosis and leprosy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Ethambutol
100%
Latent Tuberculosis
100%
Isoniazid
100%
Quinolone Derivative
100%
Linezolid
100%
Polypeptide
100%
Carbapenem Derivative
100%
Rifamycin
100%
Pyrazinamide
100%
Bedaquiline
100%
Dapsone
100%
Cycloserine
100%
Macrolide
100%
Clofazimine
100%
Aminoglycoside
100%
Aminosalicylic Acid
100%
Terizidone
100%
Thioacetazone
100%
Keyphrases
Tuberculosis
100%
Leprosy
100%
Resistance Pattern
25%
Ethambutol
25%
Drug Interactions
25%
Treatment Regimen
25%
Treatment Outcome
25%
Latent Tuberculosis Infection
25%
Adverse Effects
25%
Polypeptide
25%
World Population
25%
Fluoroquinolones
25%
Medication Effects
25%
Active Tuberculosis
25%
Linezolid
25%
Carbapenems
25%
Global Health Issue
25%
Macrolides
25%
Toxicity Profile
25%
Patient's Will
25%
Rifamycin
25%
Pyrazinamide
25%
Dapsone
25%
D-cycloserine
25%
Bedaquiline
25%
Terizidone
25%
Aminoglycosides
25%
5-aminosalicylic Acid (5-ASA)
25%
Clofazimine
25%
Thiacetazone
25%
Interaction Outcome
25%